BioLab

At BioLab we perform the biological evaluation of synthetic and natural compounds against a panel of representative human solid tumor cell lines. From this test, we determine if compounds are active and/or of interest to go into depth. We try to shed light on the mechanism of action by studying the effects of the products at a molecular level. Our ultimate goal is to identify the biological target(s) at which the active compound is directed. Additionally, we have an extensive experience to nanoshuttle these molecules to increase their bioavailability, promote their blood circulation and cell internalization, reduce drug resistance and induce a controlled drug release at the target site. While the core activities of BioLab remain in this specific topic, in the past recent years we have expanded our capacities.

BIOL4B  –  BioLab For Business
The objective of this U2T (Unit to Transfer) is to offer extramural services related to the determination of the pharmacological profile of compounds for the treatment of diseases, in particular cancer. BIOL4B will allow to interact in an agile and effective way with the market.